Dr. Mark Lambrecht, Director of the Global Health and Life Sciences Practice at SAS, joined SAS in 2005 and leads a senior team working for SAS’ healthcare and life sciences industry and organizations. His team is bringing SAS’ new HLS solutions to market and is constantly looking for innovation by identifying customer needs. He's also interested in data standards which enable the industry to share and reuse patient data to find new cures and for the benefit of mankind. Prior to joining SAS, Mark worked in the pharmaceutical industry and studied at the KU Leuven, Belgium and at Stanford University, USA. There, he worked as bioinformatics scientist specializing as a data scientist for high volumes of biological and genomics data using diverse technologies and approaches.
As in most other sectors, health care is changing at lightning speed. Access to data makes it possible to speed up clinical trials, develop more personalized medication, make quicker and better diagnoses, improve the quality of patient care and save lives. The pandemic has sped up digital transformation in every
Geen sector die de afgelopen twee jaar zo hard onder druk stond als de gezondheidszorg. En ook nu het einde van de pandemie in zicht lijkt, zullen veel uitdagingen rond Healthcare en Life Sciences niet verdwijnen. Gelukkig investeren zowel overheden als ziekenhuizen en farmaceutische bedrijven fors in data en analytics
Nos primeiros dias e semanas de qualquer problema de saúde global generalizado, particularmente num surto de rápida evolução como o coronavírus, existem muitas incógnitas. A visualização de dados pode ser um bom ponto de partida para perceber tendências e transformar dados dispersos em algo útil. A capacidade de visualizar a
